Pricing updated 2015-11-29. Prices are subject to change without notice.
Tranilast is a compound that exhibits anti-
|Formulation||A crystalline solid|
WARNING - This product is not for human or veterinary use.
|Shipping||Room temperature in continental US; may vary elsewhere|
Download Product Insert 97 Kb PDF
Download Safety Data Sheet (SDS) 24 Kb PDF
View the Cayman Structure Database for chemical structure definitions for many Cayman products
Separate multiple batch numbers with commas
1. Ikai, K., Ujihara, M., Fujii, K., et al. Inhibitory effect of tranilast on prostaglandin D synthetase. Biochem Pharmacol 38(16) 2673-2676 (1989).
2. Capper, E.A., Roshak, A.K., Bolognese, B.J., et al. Modulation of human monocyte activities by tranilast, SB 252218, a compund demonstrating efficacy in restenosis. J Pharmacol Exp Ther 295(3) 1061-1069 (2000).
3. Holmes, D.R., Savage, M., LaBlanche, J., et al. Results of prevention of restenosis with tranilast and its outcomes (PRESTO) trial. Circulation 106 1243-1250 (2002).
Koyama, S., Takagi, H., Otani, A., et al. Tranilast inhibits protein kinase C-
We offer you the deep and diverse knowledge of more than 100 in-house scientists and the expertise that comes from more than three decades of designing and developing the tools to advance biomedical research.
Cayman is know as a partner to scientists worldwide, responding to your needs with services in: